Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression

Frontiers in Aging Neuroscience(2023)10.3389/fnagi.2023.1179086Source: DataRank Database

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression is a research paper published in Frontiers in Aging Neuroscience (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

igsr

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.43)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Jeremy D. Burgess ORCID,Melina J. Lim,Danilyn Amerna,Zeynep Bengisu Kaya ORCID,Ayman H. Faroqi ORCID

Live enrichment

PubMed:37637959 PMC:PMC10449643 OpenAlex:https://openalex.org/W4385728559

NINDS NIH HHS

Grant: R01 NS092823

National Institutes of Health

Grant: 1R01NS110085-01A1

Mitochondrial Sirtuin 3 in Parkinson's disease

National Institutes of Health

Grant: 1RF1NS109157-01

Examining the role of glycosphingolipids in the progression and heterogeneity of synucleinopathies

National Institutes of Health

Grant: 5U54NS110435-02

Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.3389/fnagi.2023.1179086

publisherhttps://doi.org/10.3389/fnagi.2023.1179086

publisherhttps://www.frontiersin.org/articles/10.3389/fnagi.2023.1179086/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37637959

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10449643

Fields of Study

Magnolia and Illicium researchParkinson's Disease Mechanisms and TreatmentsBiochemical and biochemical processes03 medical and health sciences0302 clinical medicine

Keywords

SynucleinopathiesAlpha-synucleinNeuroprotectionDownregulation and upregulationGene expressionBiologyCell biologyMessenger RNAMolecular biologyChemistryParkinson's diseaseGeneNeuroscienceMedicineBiochemistryPathologyDiseasePolyphenoltherapeutic targetNatural compoundParkinson’s DiseaseSncaAlpha-synuclein (Αsyn)Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571